Statistics for Anika Therapeutics (id:8063 ANIK)

Valuation metrics

Market cap

252.64M

Enterprise value

217.80M

Trailing P/E (ttm)

-3.05

Forward P/E

-86.25

PEG ratio

-86.25

Price/Sales (ttm)

1.54

Price/Book (mrq)

1.41

Enterprise Value/Revenue

1.33

Enterprise Value/EBITDA

-27.04

Overview

Shares outstanding

14.65M

Float

10.63M

Shares short

484.38K

% Held by insiders

0.03%

% Held by institutions

0.91%

Average volume (10 days)

169.37K

Average volume (90 days)

Price summary

52-Week low

16.00

52-Week high

29.12

52-Week change

-23.52%

Beta

0.86

50-Day moving average

22.96

200-Day moving average

25.07

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-59.40%

Operating margin

-64.29%

Operational effectiveness

Return on assets

-4.01%

Return on equity

-43.31%

Income statement

Revenue (ttm)

11.14

Revenue per share (ttm)

11.14

Quarterly revenue growth (yoy)

Gross profit (ttm)

103.09M

EBITDA

50.96M

Net income to common (ttm)

-97,520,000.00

Diluted EPS (ttm)

-6.64

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

62.37M

Total cash per share (mrq)

4.26

Total debt (mrq)

27.53M

Total Debt/Equity (mrq)

15.31

Current ratio (mrq)

533.90%

Book value per share (mrq)

12.24

Cash flow

Cash flow statement

7.46M

Levered free cash flow (LFCF)

14.08M